Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases

Clinical trial NCT01836653 · COMPLETED

Trial details

NCT number: NCT01836653
Sponsor: EPS Corporation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Liver Only Metastasis From KRAS Exon 2 Wild Type (Under Protocol 1.0-1.2 Edition) and RAS Wild Type (Under Protocol 2.0 Edition) Colorectal Cancer

Start date: 2013-05-01
Primary completion: 2017-03-01
Enrollment: 122

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.